Lobbying registrant · LD-2 disclosures
Pardes Biosciences, Inc.
California
6 filings · 1 client · 1 lobbyist registered · 2022–2023 · latest filed Apr 12, 2023
Fees billed to clients
$0
never billed a fee — files for itself
Its own lobbying spend
$720K
filed on its own behalf
Clients represented
1
1 lobbyist registered
Reported spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who they lobby for
This registrant files only on its own behalf — it has never reported a fee for representing anyone else.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee charged to a client.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR · 1 client
6 filings
$720K on those filings
Medical/Disease Research/Clinical Labs
MED · 1 client
6 filings
$720K on those filings
Medicare/Medicaid
Who does the lobbying
Every lobbyist named on this registrant's filings.
- John MartinCovered position: Principal Associate Commissioner, FDA Legislative Affairs, Sen. Tom Cotton7 filings1 client · through 2023
Covered positions · 1 of 1 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: pardes-biosciences-inc.